Department of the Army, DoD.
In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(I)(i), announcement is made of the intent to grant an exclusive, royalty-bearing, revocable license to U.S. patent number 6,399,332 issued June 4, 2002 entitled “Bacterial Superantigen Vaccines,” and U.S. patent number 6,713,284 issued March 30, 2004 entitled “Bacterial Superantigen Vaccines,” and all pending foreign patents to Integrated Biotherapeutics, Inc. with its principal place of business at Frederick Innovative Technology Center, Rosenstock Hall, Frederick, MD 21702.
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.End Further Info End Preamble Start Supplemental Information
Anyone wishing to object to the grant of this license can file written objections along Start Printed Page 47783with supporting evidence, if any, 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES).Start Signature
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 06-7007 Filed 8-17-06; 8:45am]
BILLING CODE 3710-08-M